Consistent with the present findings, CD44 expression is associated with poor prognostic outcome of glioma (38, 39), BLCA (40), STAD (41, 42), HNSCC (43), KIRC (44), LIHC (45), PAAD (46),MESO (47),and THYM (48). The gene discussed is CD44; the disease is central nervous system cancer.